2021
DOI: 10.1016/j.phymed.2021.153726
|View full text |Cite
|
Sign up to set email alerts
|

Upregulation of UGT1A1 expression by ursolic acid and oleanolic acid via the inhibition of the PKC/NF-κB signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 32 publications
0
5
1
Order By: Relevance
“…21,22 P. vulgaris is rich in terpenoids, especially triterpenoids. [23][24][25] However, several studies have reported that the triterpenoid acids from P. vulgaris exhibit pro-apoptosis activity, [26][27][28] which is inconsistent with our preliminary experimental results. Our preliminary experiment has revealed that the ethanol extracts of P. vulgaris possess considerable neuroprotective effects (data not shown).…”
Section: Introductioncontrasting
confidence: 99%
“…21,22 P. vulgaris is rich in terpenoids, especially triterpenoids. [23][24][25] However, several studies have reported that the triterpenoid acids from P. vulgaris exhibit pro-apoptosis activity, [26][27][28] which is inconsistent with our preliminary experimental results. Our preliminary experiment has revealed that the ethanol extracts of P. vulgaris possess considerable neuroprotective effects (data not shown).…”
Section: Introductioncontrasting
confidence: 99%
“…OA significantly attenuated CDDP-induced NF-κB activation reported previously by our group, 27 leading to the regulation of inflammatory cytokines release and ultimately the nephroprotection. 50,51…”
Section: Resultsmentioning
confidence: 99%
“…OA signicantly attenuated CDDP-induced NF-kB activation reported previously by our group, 27 leading to the regulation of inammatory cytokines release and ultimately the nephroprotection. 50,51 Hence, we can say that OA addition to the CDDP combination chemotherapy in our system (CDDP/OA-LCC NPs) makes it an ideal therapy for combating nephrotoxicity in patients receiving CDDP chemotherapy.…”
Section: Oa Alleviates Cddp-induced Nephrotoxicity In Micementioning
confidence: 95%
“…Among these compounds, reynosin (PubChem CID 482788) was revealed to decrease inflammatory cytokine release. Carabrol (PubChem CID 15690483) and ursolic acid (PubChem CID 64945) were reported to exert an anti-inflammatory effect by inhibiting NF-κB activation [ 49 , 50 ]. (+/−)-Abscisic acid (PubChem CID 5375199) was found to suppress NLRP3 inflammasome and NF-κB activation to ameliorate inflammation [ 51 , 52 ].…”
Section: Discussionmentioning
confidence: 99%